Stoke Therapeutics, Inc. (STOK) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Stoke Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.998 Good day and thank you for standing by. Welcome to the Stoke Therapeutics third quarter 00:00:04.998 -- 00:00:06.881 2025 00:00:06.881 -- 00:00:09.644 business and financial update. 00:00:09.644 -- 00:00:12.709 At this time, all participants are in listen only mode. 00:00:12.709 -- 00:00:17.435 After the speaker's presentation, there will be a question and answer session to ask 00:00:17.435 -- 00:00:21.140 a question. During this session, you need to press star one one on your telephone. 00:00:21.140 -- 00:00:26.127 You would then hear an automated message advising your hand is raised to withdraw your 00:00:26.127 -- 00:00:28.718 question. Please press star one one again. 00:00:28.718 -- 00:00:32.383 Please be advised that today's conference is being recorded. 00:00:32.383 -- 00:00:36.790 I would now like to hand the conference over to your first speaker today, Thomas Leggett, 00:00:36.790 -- 00:00:41.354 Chief Financial Officer. Please go ahead. 00:00:41.697 -- 00:00:46.604 Good afternoon and welcome to Stoke Therapeutics' third quarter 2025 conference call. 00:00:46.604 -- 00:00:50.350 I'm Thomas Leggett, Chief Financial Officer at Stoke Therapeutics. 00:00:50.350 -- 00:00:54.015 Joining me are Ian Smith, our Chief Executive Officer, and Dr. 00:00:54.015 -- 00:00:58.589 Barry Tico, Chief Medical Officer. Jason Hoyt, Chief Patient Officer, will join us for 00:00:58.589 -- 00:01:03.476 the Q&A portion. Today's webcast presentation is available in the Investor News section 00:01:03.476 -- 00:01:09.382 of our website. It is being recorded and will be available for replay later today. 00:01:09.426 -- 00:01:13.833 Before we begin, please note that today's discussion includes forward-looking statements. 00:01:13.833 -- 00:01:18.580 Thes...